POSA70 Budget Impact Analysis of Avelumab Plus Best Supportive Care (BSC) vs BSC Alone as First-Line (1L) Maintenance Treatment in Patients With Locally Advanced (LA) or Metastatic Urothelial Carcinoma (mUC) in Taiwan
Abstract
Authors
YC Tsai AY Lin J Huang E Wu K Liu R Palencia J Chang M Kearney